» Sitio en español |» Contact

Our experience

your quality of life


of renowned therapeutic action


to providing high quality products

Laboratorio Varifarma | Compromiso con la calidad

| Divisions

| News

New Clinical Evidence.

KYPROLIS®: Significantly improves overall survival in patients with relapsed multiple myeloma, demonstrated in two Phase 3 Studies.

» view more

| News


Amgen has entrusted us with the representation of two new licences: Neupogen (filgrastim) and Neulastim (pegfilgrastim).

» view more
Copyright ©2018 - Laboratorio Varifarma S.A. |